Cite
HARVARD Citation
Cutler, A. et al. (2022). Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study to Evaluate the Efficacy and Safety of the Amphetamine Extended-Release Tablet in Adults with Attention-Deficit/Hyperactivity Disorder. CNS spectrums. pp. 242-243. [Online].